Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
---|
10/15/2009 | WO2009053934A3 Use of metal astringents for the treatment and prevention of hairy heel warts |
10/15/2009 | US20090258938 Administration of 6'-ethyl lepimectin, 6' -methyl lepimectin or derivatives thereof for treating dermatological disorders in humans |
10/15/2009 | US20090258936 Cxcr2 inhibitors |
10/15/2009 | US20090258906 Cxcr2 antagonists |
10/15/2009 | US20090258884 Substituted amides |
10/15/2009 | US20090258849 Nitrooxy derivatives of glucocorticoids |
10/15/2009 | US20090258841 Compositions and methods for skin care |
10/15/2009 | US20090258838 Gel formulation |
10/15/2009 | US20090258837 Analogous compounds of 6-thioguanosine triphosphate, their use in medical fields and processes for their preparation |
10/15/2009 | US20090258421 Embryonic stem cells and neural progenitor cells derived therefrom |
10/15/2009 | US20090258094 Xanthohumol-enriched hop extract |
10/15/2009 | US20090258093 Use of a brassocattleya marcella koss orchid extract as an active agent to prevent or delay the appearance of signs of cutaneous aging |
10/15/2009 | US20090258085 Emulsions and methods of their production |
10/15/2009 | US20090258065 Dermatological compositions comprising avermectin nanocapsules |
10/15/2009 | US20090258059 Stabilized foam for medical PSA substrate |
10/15/2009 | US20090258041 Protection of Oxidizable Agents |
10/15/2009 | US20090258013 Novel compositions and methods for the treatment of immune related diseases |
10/15/2009 | US20090257986 Epidermal and dermal equivalents |
10/15/2009 | US20090257971 Antiperspirant composition |
10/15/2009 | DE102008018304A1 Topical product, useful e.g. to prevent skin wrinkling caused by e.g. thrombophilia, comprises branched amino acids, N-hydroxy-L-arginine, boric acid derivative, chloroquine as arginase inhibitor and/or complex agent for manganese ion |
10/15/2009 | DE102008017853A1 Thienopyrimidine Thienopyrimidines |
10/15/2009 | CA2720756A1 Stabilized oleosome preparations and methods of making them |
10/15/2009 | CA2720755A1 Controlled release of active agents from oleosomes |
10/15/2009 | CA2710554A1 Methods and compositions related to internalizing rgd peptides |
10/14/2009 | EP2108655A1 Immune-modulating peptide |
10/14/2009 | EP2108370A1 Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent |
10/14/2009 | EP2108369A1 Compounds for the treatment of immunosuppression in the skin caused by aggressive agents |
10/14/2009 | EP1755604B1 Use of opioid receptor antagonist compounds for the prevention and/or treatment of diseases associated with the target calcineurin |
10/14/2009 | EP1534339B1 Topical anhydrous and ethanol-free pimecrolimus compositions |
10/14/2009 | EP1397137B1 Hydantion derivatives as inhibitors of matrix metalloproteinases |
10/14/2009 | EP1337527B1 Indolylmaleimide derivatives as protein kinase c inhibitors |
10/14/2009 | CN101555213A Preparation method of N-(phenelyl)-2-hydroxybenzamide |
10/14/2009 | CN101554464A Soaking powder for early prevention of chilblain |
10/14/2009 | CN101554463A Drug for treating gynecologic and andrological diseases and preparation method thereof |
10/14/2009 | CN101554461A Medicine for treating psoriasis and preparation method of capsule thereof |
10/14/2009 | CN101554449A Traditional Chinese medicine for traumatic curing |
10/14/2009 | CN101554447A External medicament for curing hair loss |
10/14/2009 | CN101554442A Oral blood-clearing preparation |
10/14/2009 | CN101554437A New use of Chinese herbal medicines including rhizoma alismatis, oldenlandia diffusa and coptis for clearing away pneumogastric heat and treating acne |
10/14/2009 | CN101554429A New use of Chinese herbal medicines including cortex lycii radicis, cortex moutan and raw hawthorn for clearing away the lung-heat, detoxicating and treating acne |
10/14/2009 | CN101554424A Traditional Chinese medicine for treating skin diseases and preparation method thereof |
10/14/2009 | CN101554419A Hawthorn paste for treating chilblain and making method thereof |
10/14/2009 | CN101554415A Anti-acne toner and preparation method thereof |
10/14/2009 | CN101554411A Method for dispensing prescription for treating burn and scald |
10/14/2009 | CN101554405A Selfheal, mulberry leaf and wild chrysanthemum dripping pills and preparation method thereof |
10/14/2009 | CN101554398A Externally applied medical ointment for treating surgical infection and gout and preparation method thereof |
10/14/2009 | CN101554395A New use of Chinese herbal medicines including pollen, dahurian angelica and honeysuckle flower for reducing fever, detoxicating and treating acne |
10/14/2009 | CN101554389A Botulinus toxin composition and preparation method thereof |
10/14/2009 | CN101554369A External spraying agent and eye drop of compound oil nano-emulsion as well as preparation method thereof |
10/14/2009 | CN101554362A Composition of natural product and preparation thereof |
10/14/2009 | CN100548996C 5-phenylthiazole derivatives and its use for preparing medicine |
10/14/2009 | CN100548379C Preparation for skin external use |
10/14/2009 | CN100548371C Composition containing lactobacillus acidophilus and application thereof |
10/14/2009 | CN100548370C Spray for treating burns, scalds and chronic ulcer and its preparation |
10/14/2009 | CN100548334C Ointment for treating skin ulcer (ulcer-treating capsule) and preparation process thereof |
10/14/2009 | CN100548327C External-applied medicine for treating pruritus skin diseases and its preparation method |
10/14/2009 | CN100548303C Combination product comprising melagatran and dexamethasone |
10/14/2009 | CN100548289C Anthranilic acid amides and the derivatives thereof as cosmetic and pharmaceutical agents |
10/13/2009 | US7601850 less hypercalcemic than 1a,25 dihydroxy vitamin D3; bone disorders, psoriasis |
10/13/2009 | US7601843 4-(2-furoyl)aminopiperidine compound useful as therapeutic agent for itching |
10/13/2009 | US7601836 Pyrido[2,3-D]pyrimidine inhibitors of phosphodiesterase (PDE) 7 |
10/13/2009 | US7601817 For treating a disease medicated by TNF alpha including acute and chronic immune and immunoregulatory disorders and rheumatoid or osteo-arthritis |
10/13/2009 | US7601727 Such as 3-{4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile; janus kinase 3 inhibitors; immunosuppressive agents; asthma |
10/13/2009 | US7601712 Such as (1)-2-(4-chloro-3-((2-chloro-4-(((2S)-4-methyl-3,4-dihydro-2H-1,4-benzoxazin-2-ly)methoxy)benzoyl)amino)phenyl)-2-methylpropanoic acid; prostaglandin receptor agonists |
10/13/2009 | US7601534 Maintaining a non-differentiated state of human stem cells, while allowing cell division of said human stem cells |
10/13/2009 | US7601515 Process of high purity albumin production |
10/13/2009 | US7601360 Excitatory amino acid inhibitors for treating sensitive skins |
10/13/2009 | US7601354 Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
10/13/2009 | CA2455298C Condensed polycyclic compounds |
10/13/2009 | CA2392620C Use of melatonin for the treatment of androgenetic and diffuse alopecia |
10/13/2009 | CA2370830C Use of 2,4-diamino-3-hydroxycarboxylic acid derivatives as proteasome inhibitors |
10/13/2009 | CA2356331C Methods for glucagon suppression |
10/13/2009 | CA2322311C Heterocyclo-substituted imidazopyrazine protein tyrosine kinase inhibitors |
10/13/2009 | CA2292775C Cyanoguanidines as cell proliferation inhibitors |
10/13/2009 | CA2291218C Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and -1-oxoisoindolines and method of reducing tnf.alpha. levels |
10/13/2009 | CA2110291C Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers |
10/10/2009 | CA2627021A1 Combination natural source/local anesthetic/dual component penetration enhancer topical formulation useful for treating pain, itching and/or inflammation of the skin |
10/08/2009 | WO2009123948A2 Compounds and compositions as itpkb inhibitors |
10/08/2009 | WO2009123457A2 Compositions and methods for treating sweet itch |
10/08/2009 | WO2009123454A1 Compositions and method for reducing scar formation in wound healing |
10/08/2009 | WO2009123316A1 Heterocyclic derivative and use thereof |
10/08/2009 | WO2009123221A1 Pyrimidine derivative having cell-protecting activity and use thereof |
10/08/2009 | WO2009123215A1 Preparation for preventing or ameliorating wrinkles, to be taken orally, through injection, or through external application to skin, and cosmetic method |
10/08/2009 | WO2009123211A1 Agents for maturing, normalizing or stabilizing blood vessels and wrinkle-preventing and improving agents |
10/08/2009 | WO2009122748A1 Therapeutic agent for respiratory diseases or allergic diseases |
10/08/2009 | WO2009122710A1 Medical composition |
10/08/2009 | WO2009122045A2 Use of olive oil extract to control skin aging |
10/08/2009 | WO2009121210A1 Double-stranded polyethylene glycol modified growth hormone, preparation method and application thereof |
10/08/2009 | WO2009121183A1 Dispersinbtm, 5-fluorouracil, deoxyribonuclease i and proteinase k-based antibiofilm compositions and uses thereof |
10/08/2009 | WO2009121168A1 Extracts from plants of the tsuga genus and uses thereof in the treatment of inflammation, irritation and/or infection |
10/08/2009 | WO2009101301A3 Use of a poppy petal extract for skin nutrition |
10/08/2009 | US20090253807 Aqueous suspension preparations |
10/08/2009 | US20090253732 Production Of Polyketides And Other Natural Products |
10/08/2009 | US20090253683 7-membered ring compound and method of production and pharmaceutical application thereof |
10/08/2009 | US20090253679 New imidazolone derivatives, preparation thereof as drugs, pharmaceutical compositions, and use thereof as protein kinase inhibitors, in particular cdc7 |
10/08/2009 | US20090253668 such as N-[(2,4-Dihydroxyphenyl)ethylidene]cysteine zinc salt for topical application; antiaging agents, antigreying agents |
10/08/2009 | US20090253631 Anti-Inflammatory Peptides |
10/08/2009 | US20090253627 Lactoferrin compositions and methods of wound treatment |
10/08/2009 | US20090253125 Denaturat stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same, their uses and methods of increasing a specific activity thereof |
10/08/2009 | US20090252815 Pulverulent mixtures containing hydrogen peroxide and hydrophobized silicon dioxide |